Related Experiment Videos
[Ultrasound contrast agents for liver diagnostics]
A-J Lemke1, S S Chopra, S M Niehues
1Klinik für Strahlenheilkunde des Campus Virchow-Klinikums, Charité -- Universitätsmedizin Berlin. lemke@charite.de
Der Radiologe
|May 25, 2005
Summary
Ultrasound contrast agents are crucial for diagnosing liver tumors, aiding in detection, characterization, and therapy monitoring. Their dispersion behavior influences enhancement patterns, similar to CT scans.
Area of Science:
- Medical imaging
- Oncology
- Radiology
Background:
- Ultrasound contrast agents are widely adopted for liver tumor diagnostics.
- Contrast-enhanced ultrasound (CEUS) plays a dual role in detecting liver tumors and characterizing them.
- CEUS offers valuable insights into tumor staging, including metastasis detection.
Purpose of the Study:
- To highlight the diagnostic and therapeutic applications of ultrasound contrast agents in liver tumors.
- To explain the significance of contrast agent dispersion in tumor characterization.
- To compare CEUS enhancement patterns with those from contrast-enhanced computed tomography (CECT).
Main Methods:
- Utilizing ultrasound contrast agents for enhanced liver imaging.
- Analyzing the dispersion behavior of contrast agents.
- Correlating enhancement patterns with known radiological findings.
Main Results:
- Ultrasound contrast agents effectively aid in the detection of liver tumors.
- Dispersion characteristics of agents are key to accurate tumor characterization.
- Enhancement patterns observed in CEUS largely mirror those seen in CECT.
Conclusions:
- Contrast-enhanced ultrasound is a versatile tool for liver tumor management.
- CEUS is valuable for monitoring ablative therapies and visualizing challenging vasculature.
- Liver transit time measurement is another application of CEUS.